*MEDICATION*: Pharmacy First - Impetigo treatment

[chrisjwood16]

User requirements

This codelist is used to identify supply of any medication included in the Pharmacy First Patient Group Directions for treatment of impetigo.

Sensitivity versus specificity

Specific to only the strength/formulations included in the PGDs for impetigo.

Relevant definitions or links to important reference sources

PGDs: https://www.england.nhs.uk/wp-content/uploads/2023/11/PRN01010-3a.-Impetigo-hydrogen-peroxide-cream-protocol-Pharmacy-First.pdf https://www.england.nhs.uk/wp-content/uploads/2023/11/PRN01010-3b.-Impetigo-fusidic-acid-cream-patient-group-direction-Pharmacy-First.pdf https://www.england.nhs.uk/wp-content/uploads/2023/11/PRN01010-3c.-Impetigo-flucloxacillin-patient-group-direction-Pharmacy-First.pdf https://www.england.nhs.uk/wp-content/uploads/2023/11/PRN01010-3d.-Impetigo-clarithromycin-patient-group-direction-Pharmacy-First.pdf https://www.england.nhs.uk/wp-content/uploads/2023/11/PRN01010-3e.-Impetigo-erythromycin-patient-group-direction-Pharmacy-First.pdf

Coding system

dm+d

Existing relevant codelists

N/A

Search terms / synonyms / search strategy

• Crystacide
• Hydrogen peroxide
• Fusidic acid
• Flucloxacillin
• Clarithromycin
• Erythromycin

Inclusion criteria for codes

• Hydrogen peroxide 1% (10mg/1g) cream (e.g. Crystacide® 1% cream)
• Fusidic acid 20mg/g (2%) cream
• Flucloxacillin 250mg capsules
• Flucloxacillin 500mg capsules
• Flucloxacillin 125mg/5mL oral solution (or oral suspension)
• Flucloxacillin 125mg/5mL sugar free oral solution (or oral suspension)
• Flucloxacillin 250mg/5mL oral solution (or oral suspension)
• Flucloxacillin 250mg/5mL sugar free oral solution (or oral suspension)
• Clarithromycin 250mg tablets
• Clarithromycin 125mg/5mL oral suspension (or oral solution)
• Clarithromycin 250mg/5mL oral suspension (or oral solution)
• Erythromycin 250mg tablets
• Erythromycin 250mg gastro-resistant tablets
• Erythromycin 500mg tablets
• Erythromycin 125mg/5mL oral suspension (or oral solution)
• Erythromycin 125mg/5mL sugar free oral suspension (or oral solution)
• Erythromycin 250mg/5mL oral suspension (or oral solution)
• Erythromycin 250mg/5mL sugar free oral suspension (or oral solution)
• Erythromycin 500mg/5mL oral suspension (or oral solution)
• Erythromycin 500mg/5mL sugar free oral suspension (or oral solution)

Exclusion criteria for codes

Strengths/formulations not listed above.

Borderline cases

Clarithromycin granules for oral solution, erythromycin capsules - excluded as form not included in PGD.

Final codelist

Published: BNF code format: https://www.opencodelists.org/codelist/opensafely/pharmacy-first-impetigo-treatment/099de038/

dm+d code format: https://www.opencodelists.org/codelist/opensafely/pharmacy-first-impetigo-treatment-dmd/708e6d02/

[a-d-brown]

Consider adding:

• Erythroped A 500mg tablets (0501050H0BDAIAE)
• Erythroped Forte SF 500mg/5ml oral suspension (0501050H0BDAPAN)
• Erythroped PI SF 125mg/5ml oral suspension (0501050H0BDANAL)
• Erythroped SF 250mg/5ml oral suspension (0501050H0BDAMAM)

There's limited prescribing of these items (in most cases none), and none of them are listed in EMC, so I think they're unlikely to be very important. But probably still makes sense to add for completeness, and consistency in approach.

On the other hand, if the preference is to exclude products where there is no prescribing and they're not listed in EMC, then there's probably a few other items we could remove from the codelist such as:

• Rommix 250 EC tablets (0501050C0BIAAAB)

Otherwise, all looks good to me. @chrisjwood16

[chrisjwood16]

@a-d-brown Not sure what happened there. They should have been included - updated version here: https://www.opencodelists.org/codelist/user/chriswood/pharmacy-first-impetigo-treatment/099de038/

[a-d-brown]

@chrisjwood16 - checked, all correct.

[chrisjwood16]

Published: BNF code format: https://www.opencodelists.org/codelist/opensafely/pharmacy-first-impetigo-treatment/099de038/

dm+d code format: https://www.opencodelists.org/codelist/opensafely/pharmacy-first-impetigo-treatment-dmd/708e6d02/